Ratings H.U. Group Holdings, Inc.

Equities

4544

JP3822000000

Delayed Japan Exchange Other stock markets 02:00:00 2024-05-10 am EDT			5-day change	1st Jan Change
2,198 ^JPY	+0.34%		-3.64%	-17.50%

May. 02	H.U. Group Cuts Forecasts for Fiscal Year Ended March 31	MT
Apr. 26	H.U. Group Holdings, Inc. Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024	CI

Summary

From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
The company has a good ESG score relative to its sector, according to Refinitiv.

Strengths

The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
The company's share price in relation to its net book value makes it look relatively cheap.
This company will be of major interest to investors in search of a high dividend stock.
Historically, the company has been releasing figures that are above expectations.

Weaknesses

As estimated by analysts, this group is among those businesses with the lowest growth prospects.
The company's earnings growth outlook lacks momentum and is a weakness.
The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
Low profitability weakens the company.
The company is highly valued given the cash flows generated by its activity.
For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
Most analysts recommend that the stock should be sold or reduced.
The overall consensus opinion of analysts has deteriorated sharply over the past four months.
Over the past twelve months, analysts' opinions have been revised negatively.
Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Healthcare Facilities & Services

	1st Jan change	Capi.	ESG Refinitiv
H.U. GROUP HOLDINGS, INC.	-17.50%	801M	A-
SONIC HEALTHCARE LIMITED	-16.58%	8.49B	B+
RADNET, INC.	+58.90%	4.08B	C+
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-39.78%	2.42B	B-
SYNLAB AG	-10.33%	2.42B	-
DR. LAL PATHLABS LIMITED	-8.91%	2.33B	B-
NEOGENOMICS, INC.	-2.53%	2.01B	C-
FLEURY S.A.	-19.90%	1.53B	A-
DIAN DIAGNOSTICS GROUP CO.,LTD.	-38.30%	1.26B	C+
METROPOLIS HEALTHCARE LIMITED	+2.19%	1.07B	B+

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes